During the past decade, The Parkinson's Institute, 675 ALMANOR AVENUE conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Parkinson's Institute, 675 ALMANOR AVENUE" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator and "University of Rochester" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "The Parkinson's Institute, 675 ALMANOR AVENUE" are "Parkinson Disease" (1 trials) and "Parkinson's Disease" (1 trials). Many other conditions were trialed in "The Parkinson's Institute, 675 ALMANOR AVENUE" in a lesser frequency.

Most popular intervention types in "The Parkinson's Institute, 675 ALMANOR AVENUE" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Coenzyme Q10 with vitamin E" (1 trials), "creatine" (1 trials), "placebo" (1 trials) and "placebo with vitamin E" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Parkinson's Institute, 675 ALMANOR AVENUE" are 2 trials for "All" genders.

Currently, there are NaN active trials in "The Parkinson's Institute, 675 ALMANOR AVENUE". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The Parkinson's Institute, 675 ALMANOR AVENUE, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Parkinson's Institute, 675 ALMANOR AVENUE, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".